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Objectives : The objective of this study is to estimate the
economic costs of cancer on society. 
Methods : We estimated the economic burden of people
with cancer in South Korea. To perform the analysis, we
reviewed the records of people who were cancer patients
and those who were newly diagnosed with cancer. The
data was compiled from the National Health Insurance
Corporation, which included the insurance claims database,
a list of cancer patients, a database that records the cancer
rates, the Korea Central Cancer Registry Center s cancer
patient registry database and the Korea National Statistical
Office s causes of death database. We classified the costs
as related to cancer into direct costs and indirect costs, and
we estimated each cost. Direct costs included both medical
and non-medical care expenses and the indirect costs
consisted of morbidity, mortality and the caregiver s time
costs. 
Results : The total economic costs of cancer in South
Korea stood at 14.1 trillion won in 2005. The largest amount
of the cost 7.4 tr i l l ion won, was the mortal i ty costs.
Following this were the morbidity costs (3.2 trillion won), the
medical care costs (2.2 trillion won), the non-medical care
costs (1.1 t r i l l ion won) and the costs related to the
caregiver s time (100 billion won). As a result, the economic
cost of cancer to South Korea is estimated to be between
11.6 trillion won to 14.1 trillion won for the year 2005. 
Conclusions : We need to reduce the cancer burden
through encouraging people to undergo early screening for
cancer and curing it in the early stage of cancer, as well as
implementing policies to actively prevent cancer.  
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Table 1. Number of patients by sex, age and cancer site, Korea, 2005
Cancer Site
Total
no. % no. % no. % 0-14 15-19 20-29 30-39 40-49 50-59 60-69 70+
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2,397 (Table 4).




































































* Unit: Thousand Korean Won, Unit: Million Korean Won, Divided by Korean Medical law
Table 4. Non-medical care expenses by cancer site, Korea, 2005
Cancer Site










































































































































































































































































* Unit: Thousand Korean Won, Unit: Million Korean Won, CAM was Complementary and Alternative Medicine, 
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22.8%), (2.2 , 15.7%), 
(1.1 , 8.0%), 
(0.1 , 0.9%) (Table 6). 
2.46
(2.40 ) 2
Table 7. Sensitivity analysis






Guardian s time costs















* The wages of people whose age are between 65-69 are
equivalent to half of the wages of people whose age are
between 60-64, Unit: Million Korean Won
11,610,317 - 14,075,065
Table 5. Morbidity and mortality costs by cancer site, Korea, 2005
Cancer Site





































































































































































































































































* Unit: Thousand Korean Won, Unit: Million Korean Won, Value of lifetime earnings was discounted at 3%
Table 6. Socioeconomic costs of cancer, Korea, 2005 
Type of costs N Per person* Total %
Inpatient 
Outpatient 
Subtotal (medical care costs) 
Transportation
Caregiver time 
Complementary and alternative medicine
Subtotal(non-medical care costs) 
Morbidity 
Mortality (discounted at 3%)
Guardian s time
Subtotal (Indirect costs) 

















































* Unit: Thousand Korean Won, Unit: Million Korean Won
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